Chimera Capital Management Portfolio holdings
Top Buys
| 1 |
Macy's
M
|
+$14.9M |
| 2 |
Brinker International
EAT
|
+$11.1M |
| 3 |
Build-A-Bear
BBW
|
+$9.54M |
| 4 |
HIBB
Hibbett, Inc. Common Stock
HIBB
|
+$9.34M |
| 5 |
Designer Brands
DBI
|
+$8.87M |
Top Sells
| 1 |
Signet Jewelers
SIG
|
+$34.8M |
| 2 |
Crocs
CROX
|
+$26.4M |
| 3 |
Sally Beauty Holdings
SBH
|
+$15.2M |
| 4 |
Medifast
MED
|
+$9.6M |
| 5 |
Abercrombie & Fitch
ANF
|
+$9.2M |
Sector Composition
| 1 | Consumer Discretionary | 69.85% |
| 2 | Communication Services | 9.36% |
| 3 | Consumer Staples | 7.24% |
| 4 | Technology | 4.13% |
| 5 | Industrials | 3.32% |
Similar funds
Chimera Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Chimera Capital Management held 288 positions worth $359M, down 0.23% from $360M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Chimera Capital Management withdrew a net $22.8M in Q4 2022, closing 96 positions and reducing 45 holdings. Its most notable exit was Signet Jewelers, an estimated $34.8M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 70% of assets, down from 73% a quarter earlier, followed by Communication Services and Consumer Staples.
Against the trend, Chimera Capital Management opened a new position in Macy's worth $15M.
- Chimera Capital Management's largest Q4 2022 buy was Macy's: 725,733 shares worth $15M.
- Chimera Capital Management added most to Designer Brands in Q4 2022, an estimated $8.87M increase.
- Chimera Capital Management's biggest Q4 2022 reduction was Crocs, cutting an estimated $26.4M.
- Chimera Capital Management fully exited Signet Jewelers in Q4 2022, selling an estimated $34.8M.
- Chimera Capital Management's ten largest holdings make up 31% of its $359M portfolio in Q4 2022.
- Chimera Capital Management opened 109 new positions and closed 96 in Q4 2022.
- Chimera Capital Management's portfolio value fell 0.23% quarter-over-quarter to $359M.
Based on Chimera Capital Management's 13F filing for Q4 2022, filed 15 Feb 2023.